News
MedPage Today on MSN17h
Gene-Driven Adjuvant Therapy for NSCLC Leads to Big Improvement in DFSCHICAGO -- Biomarker-driven adjuvant therapy for intermediate/high-risk non-small cell lung cancer (NSCLC) led to ...
Annual Meeting held in Chicago, IL, was host to a State of the Science session on novel diagnostics and therapeutics in renal cell and urothelial carcinomas. Dr. Michael Hofman presented an in-depth ...
(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, was host to a State ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback